Long Term Results of Balloon-Occluded Retrograde Transvenous Obliteration for Portosystemic Shunt Encephalopathy in Patients with Liver Cirrhosis and Portal Hypertension

Hiroto Inoue, Keigo Emori, Atsushi Toyonaga, Kazuhiko Oho, Masafumi Kumamoto, Tsuyoshi Haruta, Keiichi Mitsuyama, Osamu Tsuruta, Michio Sata

The Kurume Medical Journal · 2014 · 18 citations · 24 references

DOIFull text

Open access

Concepts

Abstract

This study examined 19 patients with portosystemic shunt encephalopathy caused by a splenorenal shunt (SRS), which was treated with balloon-occluded retrograde transvenous obliteration (B-RTO). Long-term treatment outcomes were evaluated based on hepatic functional reserve and vital prognosis. Encephalopathy improved in all patients after shunt embolization and closure. Albumin, serum ammonia, and the Child-Pugh score, a measure of liver function, were significantly improved 3 years after B-RTO, and exacerbation of damage to liver function was avoided (p<0.01). During the follow-up period, three patients died from liver failure and two patients from hepatocellular carcinoma. Patients had a poor prognosis if their albumin levels were less than 2.8 mg / dL before B-RTO (p<0.05). Encephalopathy patients had complete response to B-RTO, but long-term prognosis was affected by hepatic functional reserve before B-RTO and by concurrent hepatocellular carcinoma. The results of this study suggest that in patients with SRS, it is important to perform B-RTO at an early stage when the hepatic functional reserve is still satisfactory.

References

24